Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2389]
News [5185]
Articles [212]
Editorials [8]
Conferences [138]
elearning [14]
IMPAKT 2013: Everolimus can overcome trastuzumab resistance in HER-2 positive early breast cancer
IMPAKT 2013: Everolimus can overcome trastuzumab resistance in HER-2 positive early breast cancer
Personalised radiotherapy treatment set to benefit from CERN software
Personalised radiotherapy treatment set to benefit from CERN software
Announcing the 2nd Summer School in Computational Oncology and 1st p-medicine Summer School
Announcing the 2nd Summer School in Computational Oncology and 1st p-medicine Summer School
IMW 2013: Characterisation of minimal residual disease in an era of complete response in multiple myeloma
IMW 2013: Characterisation of minimal residual disease in an era of complete response in multiple myeloma
Wide consensus reached at Irish Presidency Conference on ‘Innovation and Patient Access to Personalised Medicine’
Wide consensus reached at Irish Presidency Conference on ‘Innovation and Patient Access to Personalised Medicine’
Milan Breast Cancer Conference 2013 - 30% discount for ecancer members
Milan Breast Cancer Conference 2013 - 30% discount for ecancer members
ESMO cautions era of personalised medicine not yet here
ESMO cautions era of personalised medicine not yet here
New Tumour Profiling Unit signals push for personalised cancer treatment
New Tumour Profiling Unit signals push for personalised cancer treatment
WIN Consortium and Pfizer collaborate to advance personalised cancer care
WIN Consortium and Pfizer collaborate to advance personalised cancer care
ASH 2012: Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia
ASH 2012: Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation